Article Text

Download PDFPDF

103 Case report: use of a patient controlled device for delivery of bolus doses of intrathecal analgesia in cancer related pain unresponsive to conventional pain management
  1. Tarah Cullen and
  2. Miriam Colleran
  1. HSE


Intrathecal analgesia is being used more frequently for patients with cancer pain unresponsive to regular treatments. In this case patient controlled intrathecal analgesia was used in a setting where the patient‘s pain was severe and unrelenting despite maximum tolerated doses of numerous analgesics, radiotherapy and nerve blocks. With the addition of the MyPTM device the patient‘s symptoms were markedly improved and as a result some baseline analgesia could be reduced. Though the intervention was relatively successful it did result in bothersome side effects and also brought with it new and challenging difficulties in relation to opioid management for us, the treating team to overcome.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.